126 related articles for article (PubMed ID: 3940624)
1. Serum immunosuppressive substance in patients with gynecologic malignancies and in pregnant women.
Yamashita K; Hayashi H; Mure K; Ishikawa M; Shimizu T
Cancer; 1986 Jan; 57(1):69-74. PubMed ID: 3940624
[TBL] [Abstract][Full Text] [Related]
2. [Variations in the level of immunosuppressive acidic protein in patients with gynecologic tumors and pregnant women].
Sawada M; Okudaira Y; Matsui Y; Miyoshi Y; Takayama K; Shimizu Y; Miura S
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1823-30. PubMed ID: 6882005
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppressive acidic protein in patients with gynecologic cancer.
Sawada M; Okudaira Y; Matsui Y; Shimizu Y
Cancer; 1984 Aug; 54(4):652-6. PubMed ID: 6744202
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of serum sialosyl-Tn antigen levels in comparison with CA 125 levels in gynecologic cancers.
Ryuko K; Iwanari O; Nakayama S; Iida K; Kitao M
Cancer; 1992 May; 69(9):2368-78. PubMed ID: 1562985
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of serum ferritin in female genital neoplasms].
Dong MY
Zhonghua Fu Chan Ke Za Zhi; 1991 Jan; 26(1):21-3, 61. PubMed ID: 1848498
[TBL] [Abstract][Full Text] [Related]
6. [Immunosuppressive acidic protein in patients with gynecologic cancer].
Sawada M; Matsui Y; Okudaira Y; Shimizu Y; Takayama K
Nihon Sanka Fujinka Gakkai Zasshi; 1983 May; 35(5):605-11. PubMed ID: 6408203
[TBL] [Abstract][Full Text] [Related]
7. [Value of N-acetylneuraminic acid (NANA) in the serum of patients with gynecologic cancers].
Schrempel A; Kürschner M
Zentralbl Gynakol; 1985; 107(3):175-8. PubMed ID: 3984572
[TBL] [Abstract][Full Text] [Related]
8. The clinical value of tissue polypeptide antigen in patients with gynecologic tumors.
Inoue M; Inoue Y; Hiramatsu K; Ueda G
Cancer; 1985 Jun; 55(11):2618-23. PubMed ID: 3995474
[TBL] [Abstract][Full Text] [Related]
9. [Serum ferritin and trophoblastic globulin in genital tumors in women].
Griaznova IM; Borisenko SA; Markarov OV; Fomina MB; Prokopenko PG; Tatarinov IuS
Vopr Onkol; 1990; 36(2):181-7. PubMed ID: 2180208
[TBL] [Abstract][Full Text] [Related]
10. Serum vitamins A and E and carotene in patients with gynecologic cancer.
Heinonen PK; Kuoppala T; Koskinen T; Punnonen R
Arch Gynecol Obstet; 1987; 241(3):151-6. PubMed ID: 3435184
[TBL] [Abstract][Full Text] [Related]
11. Polyamine levels in gynecologic malignancies.
Hayase R; Eguchi K; Sekiba K
Acta Med Okayama; 1985 Feb; 39(1):35-45. PubMed ID: 3984779
[TBL] [Abstract][Full Text] [Related]
12. Early hemostatic disorders in patients with gynecologic tumors.
Di Roberto P; Benedetti Panici P; Scambia G; Laghi F; Margariti PA; Mancuso S; Bompiani A
Eur J Gynaecol Oncol; 1986; 7(2):109-12. PubMed ID: 2941303
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of circulating tumor necrosis factor-alpha in patients with gynecological malignancies.
De Jaco P; Asselain B; Orlandi C; Fridman WH; Teillaud JL
Int J Cancer; 1991 May; 48(3):375-8. PubMed ID: 2040531
[TBL] [Abstract][Full Text] [Related]
14. The diagnostic value of serum copper/zinc ratio in gynecological tumors.
Brandes JM; Lightman A; Drugan A; Zinder O; Cohen A; Itskovtiz J
Acta Obstet Gynecol Scand; 1983; 62(3):225-9. PubMed ID: 6624394
[TBL] [Abstract][Full Text] [Related]
15. Cytokeratin fragment 21-1 in gynecologic malignancy: comparison with cancer antigen 125 and squamous cell carcinoma-related antigen.
Inaba N; Negishi Y; Fukasawa I; Okajima Y; Ota Y; Tanaka K; Matsui H; Iwasaki H; Sudo H; Tanaka N
Tumour Biol; 1995; 16(6):345-52. PubMed ID: 7569681
[TBL] [Abstract][Full Text] [Related]
16. [Behavior of the serum concentration of pregnancy associated alpha 2 glycoprotein (alpha 2-PAG) in gynecologic carcinomas (author's transl)].
Tatra G
Strahlentherapie; 1981 Jul; 157(7):464-7. PubMed ID: 7268817
[TBL] [Abstract][Full Text] [Related]
17. Occurrence of CA 125 and CA 19-9 tumor-associated antigens in sera of patients with gynecologic, trophoblastic, and colorectal tumors.
Göcze PM; Szabó DG; Than GN; Csaba IF; Krommer KF
Gynecol Obstet Invest; 1988; 25(4):268-72. PubMed ID: 2841208
[TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers.
Xu Y; Shen Z; Wiper DW; Wu M; Morton RE; Elson P; Kennedy AW; Belinson J; Markman M; Casey G
JAMA; 1998 Aug; 280(8):719-23. PubMed ID: 9728644
[TBL] [Abstract][Full Text] [Related]
19. Multiple biochemical markers in patients with gynecologic malignancies.
Donaldson ES; van Nagell JR; Pursell S; Gay EC; Meeker WR; Kashmiri R; van deVoorde J
Cancer; 1980 Mar; 45(5):948-53. PubMed ID: 6167342
[TBL] [Abstract][Full Text] [Related]
20. Clinical value of sialyl Tn antigen in patients with gynecologic tumors.
Inoue M; Ogawa H; Nakanishi K; Tanizawa O; Karino K; Endo J
Obstet Gynecol; 1990 Jun; 75(6):1032-6. PubMed ID: 2342728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
